Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Ford Motor Company

Pfizer

Perdoceo Education

Rio Tinto plc Sponsored

AT&T

Vipshop Hlds

The allure of high-potential dirt-cheap stocks often tempts those looking for the next big win. This year has seen some market sectors skyrocket while others remain in the shadows, with untapped potential.

7 Dirt-Cheap Stocks to Buy in August

PURCHASE, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to Hawaii residents, first responders and others directly impacted by the recent devastating wildfires.

Teladoc Health Is Providing Free Virtual Health Care Services to Hawaii Residents Impacted by Wildfires

Roku

After a challenging few years, Teladoc's bottom line and margins are moving in the right direction. Roku is seeing its revenue growth rebound and expenses drop thanks to a recovering economy.

2 Stocks With Solid Earnings Report to Buy Right Now

Teladoc's stock gained momentum since it released an encouraging earnings report last week. The company is no longer incurring hefty impairment losses, as its bottom line has been improving.

Why Teladoc Health Could Be an Extremely Underrated Buy

The world's largest virtual healthcare services provider Teladoc Health Inc. NYSE: TDOC stock is finally breaking out of its year-long bearish weekly descending triangle pattern. The 20% jump in share prices within a week was triggered by its Q2 2023 earning report.

The Recovery in Teladoc is Showing Signs of Life

Teladoc calls AI a "key theme" for the year and is using dozens of AI models for various tasks. The technology already is helping improve Teladoc's margins.

Can AI Be a Game-Changer for Teladoc?

Teladoc Health reported second-quarter earnings results on Tuesday, July 25. Teladoc narrowed its second-quarter loss to just $65.2 million from a loss of more than $3 billion a year earlier.

Is Teladoc Health a Buy Now?

Teladoc Health, Inc.'s focus on mental health services and its ability to provide accessible and effective care have positioned the company as a key player in tackling the mental health crisis. The looming physician shortage predicted by the U.S. Department of Health and Human Services serves as an impetus to adopt technological advancements. The improving cash-flow position provides Teladoc Health with the flexibility to invest in growth initiatives and continue driving innovation.

Teladoc's Future: Virtual Healthcare, AI, And Valuation

Teladoc's efforts to boost efficiency and focus on the path to profitability are bearing fruit. The company's sales of multiple products are driving growth.

Teladoc's CEO Says Clients Are Going "All-In." Time to Buy the Stock?

Teladoc posted modest top-line growth in the second quarter, and showed improvement on a key profit metric. On a GAAP basis, however, the telehealth company is still losing a lot of money.

Why Teladoc Health Stock Soared This Week

Danaher

Intuitive Surgical

Johnson & Johnson

Eli Lilly

McKesson

UnitedHealth Group

Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each year, which works out to nearly $13,000 per person.

7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes

Doximity

Teladoc is a telemedicine leader that could benefit massively from the industry's growth. Doximity's platform caters to physicians in ways that help them better serve their patients.

Better Buy: Teladoc Health vs. Doximity

Teladoc Health's (TDOC) Q2 results reflect improving access fees and other revenues coupled with lower expenses.

Teladoc Health (TDOC) Q2 Earnings Top Estimates on Lower Expenses

The telemedicine leader raised its guidance for the third quarter and the full year. The company saved money by cutting back on office space.

Why Shares of Teladoc Are Up Wednesday

Teladoc stock is up 5% after the company reported Q2 earnings. Is this Cathie Wood stock still worth it?

Teladoc Earnings: Are Better Days Ahead or Is the Growth Story Over?

Teladoc Health's shares rose nearly 7% in premarket trade on Wednesday after the telehealth operator beat Wall Street expectations for second-quarter revenue, aided by its mental health platform.

Teladoc Health rises after beating quarterly revenue expectations

Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Teladoc (TDOC) Q2 Earnings: A Look at Key Metrics

Teladoc Health, Inc. (NYSE:TDOC ) Q2 2023 Earnings Call Transcript July 25, 2023 4:30 PM ET Company Participants Patrick Feeley - Head of Investor Relations Jason Gorevic - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Sandy Draper - Guggenheim Jailendra Singh - Truist Securities Lisa Gill - JP Morgan Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity George Hill - Deutsche Bank. Charles Rhyee - TD Cowen Ryan Daniels - William Blair Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Kevin Caliendo - UBS.

Teladoc Health, Inc. (TDOC) Q2 2023 Earnings Call Transcript

Teladoc (TDOC) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.44 per share a year ago.

Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates

Teladoc Health shares rose 8.8%, to $24.80, in aftermarket trading following its latest quarterly results and current outlook.

Teladoc Health shares rise 5% following improved outlook

PURCHASE, NY, July 25, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the second quarter ended June 30, 2023.

Teladoc Health Reports Second Quarter 2023 Results

Microsoft

This represents a growing trend by healthcare organizations, which are increasingly leveraging AI to augment workflows.

Microsoft & Teladoc Expand Partnership, Enabling AI To Reduce Clinician Workload

Teladoc And Microsoft's Expanded Strategic Partnership Is A Powerful AI Combo

American Airlines

ChargePoint Holdings

JD.com

New Fortress Energy

ReneSola

StoneCo

Many bargain growth stocks with strong fundamentals are now trading at attractive valuations. These stocks have been sold off aggressively over the last two years, and remain under-appreciated.

7 Bargain Growth Stocks to Buy Before They Bounce Back

Teladoc Health's (TDOC) Q2 results are likely to have benefited from improved access fees and growing BetterHelp membership, partly offset by elevated technology and development expenses.

News for Teladoc Stock (TDOC)